
Ourofino is a Brazilian veterinary pharmaceutical company serving food-animal and companion-animal health across Latin America.
ourofino.comCrawled Nov 7, 2026
Boostin is a technology for dairy cows that supports increased milk production and lactation persistence sustainably.
Evol is a broad-spectrum endectocide for cattle, effective against gastrointestinal nematodes and resistant strains.
Ourofino Saúde Animal publishes its Salary Transparency Report, complying with Brazilian law No. 14.611.
Ourofino outlines its corporate governance, including sustainability, investor relations, transparency, and integrity.
Ourofino describes its integrity practices, including its Integrity Program, Code of Conduct, compliance, governance, and commitments to ethics and transparency.
Ourofino Saúde Animal presents its history, purpose, values, and role in developing animal health products.
Ourofino Saúde Animal offers a confidential reporting channel for ethical or conduct violations, operated independently and securely.
Ourofino Saúde Animal provides a confidential channel to report ethical or conduct irregularities.
Ourofino Saúde Animal offers contact details for inquiries about its products.
Ourofino Pet lists authorized distributors by state and city for product sales.
Ourofino Saúde Animal offers solutions for dogs, cats, cattle, horses, poultry, and pigs, ensuring care from farm to pet.
Ourofino Saúde Animal outlines its privacy policy and personal data protection under LGPD.
Ourofino Saúde Animal provides the terms and conditions for using its website.
Ourofino, Brazil’s largest veterinary pharmaceutical company, is expanding into Argentina and Uruguay by establishing sales and technical teams. The move aims to capitalize on growing livestock demand in the region. By 2030, the company also plans to further strengthen its presence in Paraguay.
Nov 2026efeedlink.comNews article
Ourofino is expanding its operations into Argentina and Uruguay. The company, known for its animal health products, is set to strengthen its presence in the Southern Cone region. This move aligns with Ourofino’s growth strategy in emerging markets.
Nov 2026valorinternationalNews article
Ourofino Saúde Animal expands its animal health operations across Latin America, operating subsidiaries in Mexico and Colombia and exporting to 14 other countries. The company’s growth strategy relies on innovation and strong partnerships with industry professionals to develop field-driven technological solutions. Its mission, 'Reimagine Animal Health,' reflects a focus on global connectivity, competitive excellence, and people-centered care.
Sep 2026Tridge InsightsNews article
Ouro Fino Saúde Animal develops animal health solutions across Latin America, combining innovation with a broad product portfolio. The company invests heavily in research and development, alongside advanced manufacturing, to serve both production and companion animal markets. Its focus on workplace excellence and financial growth strengthens its regional leadership position.
Mar 2026TradingViewNews article